Skip to search formSkip to main contentSkip to account menu

Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse

Known as: Lymphoma, Lymphocytic, Diffuse, Poorly-Differentiated, Lymphomas, Mantle-Cell, Diffuse Lymphocytic Lymphoma, Poorly-Differentiated 
An aggressive, usually diffuse non-Hodgkin lymphoma composed of small to medium sized B-lymphocytes (centrocytes). Most patients present with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Many human cancers are associated with characteristic chromosomal rearrangements, especially hematopoietic cancers such as… 
Highly Cited
2009
Highly Cited
2009
Mantle cell lymphoma (MCL) has a dismal outcome when treated with conventional chemotherapy. This single arm phase 2 study… 
Highly Cited
2008
Highly Cited
2008
The study was undertaken with the aim to outline deletion patterns involving the long arm of chromosome 6, a common abnormality… 
Highly Cited
2006
Highly Cited
2006
Purpose: Methotrexate is known to synergize with cytarabine [1-β-d-arabinofuranosylcytosine (ara-C)] in a schedule-dependent… 
Highly Cited
2003
Highly Cited
2003
Overexpression of cyclin D1 is necessary but by itself insufficient for the development of mantle cell lymphoma (MCL). To… 
Highly Cited
2002
Highly Cited
2002
Summary. We have carried out comparative genomic hybridization (CGH) analysis on archival biopsy material from a series of 30 UK… 
Highly Cited
1999
Highly Cited
1999
Conventional chromosome analysis (CCA) and interphase fluorescence in situ hybridization (FISH) was performed in 42 patients with… 
Highly Cited
1980
Highly Cited
1980
Blood lymphocytes of patients with solid tumors were assayed for cytotoxicity against autologous and allogeneic primary tumor…